GenSight Biologics S.A. | Ownership
Companies that own GenSight Biologics S.A.
Fidelity Management & Research Co.
1,548,577
6.25%
-67,219
0%
07/31/2018
AXA Investment Managers UK Ltd.
514,228
2.08%
514,228
0.01%
02/28/2018
JPMorgan Asset Management (UK) Ltd.
378,179
1.53%
0
0%
05/31/2018
APG Asset Management NV
178,571
0.72%
-19,448
0%
03/31/2018
La Financière de L’Europe SAS
150,340
0.61%
23,340
0.3%
07/31/2018
Générali Investments Europe SpA SGR (France)
50,000
0.2%
50,000
0%
12/30/2016
OFI Asset Management SA
35,000
0.14%
25,000
0%
12/29/2017
Friedland Gestion SAS
3,750
0.02%
0
0.07%
09/29/2017
Gestys SA
0
0%
-25,000
0%
03/23/2018
| Address |
74, rue du Faubourg Saint-Antoine
Paris Ile-de-France 75012
France
|
|
Employees
|
- |
| Website |
http://www.gensight-biologics.com |
| Updated |
07/08/2019 |
| GenSight Biologics SA operates as a biopharmaceutical company, which develops novel therapies for mitochondrial and neurodegenerative diseases for central nervous system based on its proprietary platform technologies that combine gene therapy on mitochondrial targeting and optogenetics. It also provides ophthalmology services, which develops products to restore eyesight to patients suffering from retinal diseases. The company was founded by Bernard Jacques Alex Gilly, Botond Roska, Jean Benn, Luk H. |
